HGF/c-Met raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-03-18 and is reviewed periodically as new material appears.
The full name often given is N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. This name indicates a chain containing tyrosine, isoleucine, and a six-carbon amino acid derivative. Databases list a CAS Registry Number and a molecular formula for the compound. The peptide is small compared with proteins, and its structure allows it to be studied in cell cultures and animal models. Exact identity depends on the supplier's synthesis and purification process. Minor impurities can remain after synthesis.
Chemically, dihexa belongs to a broader group of angiotensin IV analogs. Researchers have modified the natural peptide to alter stability, binding, or distribution. Such changes can affect how the molecule behaves in experiments. The parent peptide angiotensin IV is involved in various physiological processes, but the modified analog is not identical to it. Public summaries sometimes blur the distinction between the natural fragment and the synthetic research compound. This distinction matters when interpreting study results.
Dihexa is a synthetic peptide that has been examined in laboratory and animal research. Its design is based on angiotensin IV, a naturally occurring peptide fragment produced in the body. The short name dihexa appears in scientific papers and online discussions, while the full chemical name describes a modified peptide chain. It is not a vitamin, mineral, or plant-derived compound. Suppliers typically present it as a research chemical rather than an approved medicine.
Regulatory status varies by country, and dihexa is not widely approved as a medicine. In many jurisdictions it is treated as a research chemical, which limits its legal sale, possession, and human use. Products marketed online may lack verified purity or identity, and labels can be inaccurate. Researchers typically source material from suppliers that provide analytical documentation and follow institutional safety rules. Open questions remain about long-term stability, metabolite formation, and human pharmacokinetics.
Dihexa is typically supplied as a lyophilized powder for laboratory research. Lyophilization removes water and improves stability during transport and storage. The solid is commonly stored at -20 °C or lower, desiccated, and protected from light. Repeated freeze-thaw cycles and exposure to moisture can degrade peptides, so aliquoting and sealed containers are standard practice in most laboratory settings. These handling measures apply to research-grade material and do not imply clinical suitability.
Purity and identity are usually assessed with reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry. RP-HPLC separates components by hydrophobicity and can estimate peptide purity. Mass spectrometry confirms molecular mass and helps detect truncations or modifications. Some laboratories also use amino acid analysis or nuclear magnetic resonance for structural verification. A certificate of analysis from a supplier may list these results, but independent verification is often recommended for critical work.
| Property | Value | Notes |
|---|---|---|
| Common name | Dihexa | Shorthand used in research literature and supplier catalogs. |
| CAS Registry Number | 1401708-83-5 | Identifier assigned to the synthetic peptide. |
| Molecular formula | C27H44N4O5 | Reported formula; verify with a certificate of analysis. |
| Appearance | White to off-white powder | Typical form for lyophilized research peptides. |
| Typical storage | −20 °C or below, desiccated | Common condition for peptide stability. |
Early laboratory work focused on its effects on synaptic connectivity and neuronal signaling. In cell and animal models, dihexa has been reported to promote the formation of new synapses, a process called synaptogenesis. These findings have generated interest in cognitive research, but the evidence base remains mostly preclinical. Human clinical trials with clear safety and efficacy endpoints are limited or absent in the public literature. Whether these effects translate to humans is an open question.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
Quality control usually combines reverse-phase high-performance liquid chromatography with mass spectrometry. Chromatography estimates purity and detects related impurities, while mass spectrometry supports molecular identity. Nuclear magnetic resonance can provide additional structural confirmation when needed. Stability data for dihexa are limited, and degradation pathways may depend on pH, temperature, and moisture. Open questions include long-term stability in different formulations and the effect of repeated freeze-thaw cycles on measured purity. Such tests help confirm that a batch matches its label before use.
In laboratory settings, dihexa is typically handled as a lyophilized peptide powder. Appropriate personal protective equipment and a ventilated workspace are standard practices for weighing and transferring research chemicals. Because the compound lacks regulatory approval for clinical use, it should not be given to people. Institutional safety rules and local regulations govern its acquisition, storage, and disposal. Suppliers often provide a certificate of analysis that lists purity, identity, and batch-specific handling notes.
Regulatory status differs by country, but dihexa is generally not approved as a therapeutic product. It is often sold as a research chemical, which means purity, labeling, and handling fall outside pharmaceutical drug standards. Some jurisdictions restrict the sale of peptides intended for human consumption. Researchers and suppliers may therefore face different legal requirements depending on location. Import rules and customs enforcement can also affect how such compounds move across borders.
Human safety data are sparse. No widely accepted dosing regimen, long-term safety profile, or clinical efficacy endpoint has been established. Published animal results can suggest directions for further study, but species differences and study design limit direct translation. Open questions include bioavailability, blood-brain barrier penetration, metabolism, and whether observed effects arise from a single target or multiple pathways. Replication across independent laboratories remains an important benchmark for evaluating the strength of preclinical claims.
=== 547th Volksgrenadier Division === The 547th Volksgrenadier Division continued fighting under the 4th Army in Lithuania and, during the following month, retreated with the 4th Army to East Prussia, remaining there until January 1945. The unit was destroyed near Zinten in February 1945. The remnants of the division were distributed among other divisions. The infantry elements were transferred to the 170th Infantry Division.
However, the researchers did not have enough penicillin to help him to a full recovery, and he relapsed and died. Because of this experience and the difficulty in producing sufficient penicillin, Florey switched his focus to children, who could be treated with smaller quantities of penicillin. Florey expected that penicillin would be hailed as a breakthrough, but he was disappointed; his results aroused little interest. He spent the next two years attempting to generate interest in what he believed to be the most important medical discovery of the century. He was elected a Fellow of the Royal Society in March 1941, but his work with penicillin played little part in this.
Cervical drug delivery is a route of carrying drugs into the body through the vagina and cervix. This is a form of localized drug delivery that prevents the drugs from impacting unintended areas of the body, which can lower side effects of toxic drugs such as chemotherapeutics. Cervical drug delivery has specific applications for a variety of female health issues: treatment of cervical cancer, pregnancy prevention, STD prevention, and STD treatment.
Countercurrent chromatography and related liquid-liquid separation techniques have been used on both industrial and laboratory scale to purify a wide variety of chemical substances. Separation realizations include proteins, DNA, Cannabidiol (CBD) from Cannabis Sativa antibiotics, vitamins, natural products, pharmaceuticals, metal ions, pesticides, enantiomers, polyaromatic hydrocarbons from environmental samples, active enzymes, and carbon nanotubes. Countercurrent chromatography is known for its high dynamic range of scalability: milligram to kilogram quantities purified chemical components may be obtained with this technique. It also has the advantage of accommodating chemically complex samples with undissolved particulates. History of chromatography Supercritical fluid chromatography
Zenobi-Wong works in the area of tissue engineering, in particular for cartilage regeneration. She develops functional biomaterials which mimic the extracellular matrix. The biofabrication techniques used to develop these materials include electrospinning, casting, two-photon polymerization and bioprinting. Zenobi-Wong holds four licensed patents in the fields of tissue engineering, tissue engineering techniques, and gene expression assays. She was one of the originators of the MSc Biomedical Engineering program at ETH Zürich, and developed several graduate level courses in tissue engineering and biomedical engineering. Zenobi-Wong currently serves as President of the Swiss Society for Biomaterials and Regenerative Medicine, and as secretary general of the International Society of Biofabrication. ETH Zürich Department of Health Sciences and Technology - Tissue Engineering and Biofabrication Group Marcy Zenobi-Wong publications indexed by Google Scholar
Sources: en.wikipedia.org
=== Chemical === The chemistry of nobelium is incompletely characterized and is known only in aqueous solution, in which it can take on the +3 or +2 oxidation states, the latter being more stable. It was largely expected before the discovery of nobelium that in solution, it would behave like the other actinides, with the trivalent state being predominant; however, Seaborg predicted in 1949 that the +2 state would also be relatively stable for nobelium, as the No2+ ion would have the ground-state electron configuration [Rn]5f14, including the stable filled 5f14 shell. It took nineteen years before this prediction was confirmed. In 1967, experiments were conducted to compare nobelium's chemical behavior to that of terbium, californium, and fermium. All four elements were reacted with chlorine and the resulting chlorides were deposited along a tube, along which they were carried by a gas. It was found that the nobelium chloride produced was strongly adsorbed on solid surfaces, proving that it was not very volatile, like the chlorides of the other three investigated elements. However, both NoCl2 and NoCl3 were expected to exhibit nonvolatile behavior and hence this experiment was inconclusive as to what the preferred oxidation state of nobelium was. Determination of nobelium's favoring of the +2 state had to wait until the next year, when cation-exchange chromatography and coprecipitation experiments were carried out on around fifty thousand 255No atoms, finding that it behaved differently from the other actinides and more like the divalent alkaline earth metals.
Promising innovations relating to global challenges are reported: researchers release an AI system, SIDE, to improve source-quality and reliability of Wikipedia by identifying problematic citations and recommending better ones to editors (19 Oct), researchers demonstrate potential AI applications in science such as for research suggestion tools and keeping track of accelerating scientific output. Promising results of health and medical research are reported: breast-cancer detection via cell-free tumor DNA in breastmilk (5 Oct), monkey-tested genetically edited humanized kidney xenotransplant (11 Oct), trialed electrical brain stimulation methods against brain disorders (19 Oct), aged-rats tested blood plasma fraction E5 from young pig blood against aging as measured by cognitive function and organ biomarkers (24 Oct).
Fishes from a coral reef with diets containing different carbon sources also had variable amino acid δ13C values. Furthermore, one study observed distinct amino acid isotopic compositions for desert C3, C4, and CAM plants. These applications in diverse ecosystems highlight the versatility of compound-specific amino acid isotope analysis.
Ciskei ( səss-KY, siss-, -KAY, meaning on this side of [the river] Kei), officially the Republic of Ciskei (Xhosa: iRiphabliki yeCiskei), was a Bantustan for the Xhosa people, located in the southeast of South Africa. It covered an area of 7,700 square kilometres (3,000 sq mi), almost entirely surrounded by what was then the Cape Province, and possessed a small coastline along the shore of the Indian Ocean. Under South Africa's policy of apartheid, land was set aside for black peoples in self-governing territories. Ciskei was designated as one of two homelands, or "Bantustans", for Xhosa-speaking people. Xhosa people were forcibly resettled in the Ciskei and Transkei, the other Xhosa homeland. In contrast to the Transkei, which was largely contiguous and deeply rural, and governed by hereditary chiefs, the area that became the Ciskei had initially been made up of a patchwork of "reserves", interspersed with pockets of white-owned farms. In Ciskei, there were elected headmen and a relatively educated working-class populace, but there was a tendency of the region's black residents—who often worked in East London, Queenstown, and King Williams Town—to oppose traditional methods of control. These differences have been posited as the reason for two separate homelands for the Xhosa people being developed, as well as the later nominal independence of Ciskei from South Africa, than Transkei.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide modeled on angiotensin IV. It is used in laboratory and animal research, not as an approved medicine. Human effects remain poorly characterized.
It is produced by chemical synthesis, not extracted from plants or animals. Its design is based on a naturally occurring peptide fragment. Suppliers sell it as a research chemical.
No, dihexa is a modified analog of angiotensin IV. The two share a structural relationship but differ in chemical details. Research on one does not automatically apply to the other.
The lyophilized powder is generally stored at -20 °C or lower, desiccated, and protected from light. Solutions are often aliquoted to avoid repeated freeze-thaw cycles. Specific stability data may vary by formulation and purity.